To investigate whether REGγ promotes the progression and malignancy of KRAS-mutant cancers by cooperating with oncogenic KRAS, we conducted cell viability assays to examine the effects of REGγ knockdown on tumor cell growth in KRAS isogenic cell lines. The gene discussed is KRAS; the disease is cancer.